Brian T. Corrigan - 12 Aug 2024 Form 4 Insider Report for LEXICON PHARMACEUTICALS, INC. (LXRX)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LXRX	Stock Option (Right to Buy)	Award	$0	+200,000		$0.000000	200,000	12 Aug 2024	Common Stock	200,000	$1.60	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter.